A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 7 March 2015 |
| Author/s |
author: Mark Raffeld Seth M Steinberg Baris Turkbey James H Doroshow Zhigang Kang Cody J Peer Peter L Choyke Shivaani Kummar |
| Publication date | March 7, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |